Tenax Therapeutics, Inc. (TENX)

Revance Therapeutics Market Cap

Tenax Therapeutics has a market cap or net worth of $244.51 million as of August 1, 2025. Its market cap has increased by 3,549.36% in one year.

• Market Cap: 244.51M
• Enterprise Value: 135.44M
• 1-Year Change: 3,549.36%
• Ranking: #3547
• Category: Micro-Cap
• Stock Price: $6.16

Market Cap Chart

Since October 31, 2001, Tenax Therapeutics's market cap has increased from $13.80M to $244.51M, an increase of 1,671.79%. That is a compound annual growth rate of 12.86%.

Market Cap History

Date	Market Cap	% Change
Jul 31, 2025	25.90M	22.75%
Dec 31, 2024	21.10M	219.70%
Dec 29, 2023	6.60M	32.00%
Dec 30, 2022	5.00M	-80.92%
Dec 31, 2021	26.20M	11.49%
Dec 31, 2020	23.50M	147.37%
Dec 31, 2019	9.50M	427.78%
Dec 31, 2018	1.80M	-86.96%
Dec 29, 2017	13.80M	-74.82%
Dec 30, 2016	54.80M	-40.63%
Dec 31, 2015	92.30M	-14.54%
Dec 31, 2014	108.00M	125.94%
Dec 31, 2013	47.80M	123.36%
Dec 31, 2012	21.40M	-45.69%
Dec 30, 2011	39.40M	-13.41%
Dec 31, 2010	45.50M	-62.86%
Dec 31, 2009	122.50M	213.30%
Dec 31, 2008	39.10M	-10.93%
Dec 31, 2007	43.90M	92.54%
Dec 29, 2006	22.80M	25.97%
Dec 30, 2005	18.10M	-40.66%
Dec 31, 2004	30.50M	-57.04%
Dec 31, 2003	71.00M	332.93%
Dec 31, 2002	16.40M	18.84%
Dec 31, 2001	13.80M	-

View and export this data all the way back to 2001. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	682.35B
Johnson & Johnson	402.82B
AbbVie	334.40B
UnitedHealth Group	241.34B
AstraZeneca	236.88B
Novartis AG	227.02B
Abbott Laboratories	223.66B
Novo Nordisk	221.96B